Enzo Biochem Inc. (ENZ)
0.31
-0.07 (-18.76%)
At close: Apr 17, 2025, 3:59 PM
0.35
11.13%
After-hours: Apr 17, 2025, 08:00 PM EDT
Enzo Biochem Revenue Breakdown
| Period Ending | Jul 31, 2022 |
|---|---|
| Consolidated Member Revenue | 20.28M |
| Consolidated Member Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Jul 31, 2024 | Jul 31, 2023 | Jul 31, 2022 | Jul 31, 2021 |
|---|---|---|---|---|
| Asia Pacific Revenue | 3.86M | 4.06M | 19.78M | 102.6M |
| Asia Pacific Revenue Growth | -5.02% | -79.47% | -80.72% | n/a |
| Europe Revenue | 8.56M | 8.45M | 4.29M | 4.74M |
| Europe Revenue Growth | +1.33% | +96.74% | -9.49% | n/a |
| United States Revenue | 19.49M | 18.55M | 8.57M | 10.39M |
| United States Revenue Growth | +5.06% | +116.51% | -17.50% | n/a |
Operating Expense Breakdown
| Period Ending | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.88M | 7.8M | 4.48M | 5.07M | 7.01M | -8.08M | 12.02M | 11.81M | 11.45M | 16.75M | 11.44M | 14.47M | 11.05M | 11.8M | 12.08M | 11.01M | 10.01M | 10.07M | 11.06M | 10.69M | 11.14M | 10.88M | 10.92M | 11.5M | 10.97M | 11.48M | 11.03M | 11.07M | 10.89M | 10.87M | 10.5M | 11.16M | 11.47M | 11.21M | 10.87M | 11.28M | 10.22M | 10.97M | 10.15M | 9.67M |
| Selling, General, and Administrative Revenue Growth | -37.45% | +74.26% | -11.62% | -27.67% | -186.69% | -167.24% | +1.78% | +3.15% | -31.62% | +46.36% | -20.90% | +30.89% | -6.31% | -2.37% | +9.71% | +9.98% | -0.53% | -8.99% | +3.44% | -4.00% | +2.40% | -0.38% | -5.02% | +4.80% | -4.43% | +4.12% | -0.41% | +1.64% | +0.20% | +3.49% | -5.94% | -2.69% | +2.34% | +3.16% | -3.64% | +10.32% | -6.77% | +8.10% | +4.92% | n/a |
| Research and Development Revenue | 562K | 607K | 605K | 580K | 849K | 502K | 975K | 1.43M | 996K | 1.07M | 1.13M | 820K | 744K | 864K | 836K | 806K | 746K | 1.17M | 1.16M | 1.06M | 1.05M | 833K | 781K | 833K | 728K | 852K | 799K | 812K | 747K | 857K | 766K | 483K | 822K | 914K | 882K | 861K | 867K | 916K | 809K | 834K |
| Research and Development Revenue Growth | -7.41% | +0.33% | +4.31% | -31.68% | +69.12% | -48.51% | -31.87% | +43.67% | -6.92% | -5.56% | +38.17% | +10.22% | -13.89% | +3.35% | +3.72% | +8.04% | -36.02% | +0.26% | +9.20% | +1.04% | +26.53% | +6.66% | -6.24% | +14.42% | -14.55% | +6.63% | -1.60% | +8.70% | -12.84% | +11.88% | +58.59% | -41.24% | -10.07% | +3.63% | +2.44% | -0.69% | -5.35% | +13.23% | -3.00% | n/a |